Your browser doesn't support javascript.
loading
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II).
Boussac, Mathilde; Arbus, Christophe; Klinger, Helene; Eusebio, Alexandre; Hainque, Elodie; Corvol, Jean Christophe; Rascol, Olivier; Rousseau, Vanessa; Harroch, Estelle; d'Apollonia, Charlotte Scotto; Croiset, Aurélie; Ory-Magne, Fabienne; De Barros, Amaury; Fabbri, Margherita; Moreau, Caroline; Rolland, Anne-Sophie; Benatru, Isabelle; Anheim, Mathieu; Marques, Ana-Raquel; Maltête, David; Drapier, Sophie; Jarraya, Béchir; Hubsch, Cécile; Guehl, Dominique; Meyer, Mylène; Rouaud, Tiphaine; Giordana, Bruno; Tir, Mélissa; Devos, David; Brefel-Courbon, Christine.
Afiliación
  • Boussac M; Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France.
  • Arbus C; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.
  • Klinger H; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Lyon, France.
  • Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France.
  • Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France et Faculté de Médecine de Sorbonne Université, Paris, France.
  • Corvol JC; Sorbonne Université, Paris Brain Institute -ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, NS-PARK/FCRIN, Department of Neurology, Paris, France.
  • Rascol O; Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France.
  • Rousseau V; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • Harroch E; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • d'Apollonia CS; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • Croiset A; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • Ory-Magne F; CERPPS-Study and Research Center in Psychopathology and Health Psychology, University of Toulouse II Jean-Jaurès, Toulouse, France.
  • De Barros A; Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France.
  • Fabbri M; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • Moreau C; Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France.
  • Rolland AS; Department of Neurosurgery, Toulouse University Hospital, Toulouse, France.
  • Benatru I; Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France.
  • Anheim M; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.
  • Marques AR; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France.
  • Maltête D; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France.
  • Drapier S; Neurology Department, University Hospital of Poitiers, Poitiers, France; INSERM, CHU de Poitiers, University of Poitiers, Centre d'Investigation Clinique CIC1402, Poitiers, France.
  • Jarraya B; Service de Neurologie, Hôpitaux Universitaires de Strasbourg; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, Franc
  • Hubsch C; Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, France.
  • Guehl D; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France.
  • Meyer M; CHU Rennes, Service de neurologie, CIC-INSERM 1414, Rennes, France.
  • Rouaud T; Pôle Neurosciences, Foch Hospital, Suresnes; Université Paris-Saclay, UVSQ, INSERM U992, CEA Paris-Saclay, Neurospin, France.
  • Giordana B; Hôpital Fondation A de Rothschild, Service de recherche clinique, Paris, France.
  • Tir M; Institut des Maladies Neurodégénératives (IMN, CNRS U5393), Université de Bordeaux, Bordeaux, France.
  • Devos D; Service de Neurophysiologie Clinique, Pôle des Neurosciences Cliniques, CHU de Bordeaux, Bordeaux, France.
  • Brefel-Courbon C; Service de neurologie, Hôpital Central, CHRU de Nancy, Nancy Cedex, France.
J Parkinsons Dis ; 12(2): 699-711, 2022.
Article en En | MEDLINE | ID: mdl-34897100
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Núcleo Subtalámico / Estimulación Encefálica Profunda Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Parkinsons Dis Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Núcleo Subtalámico / Estimulación Encefálica Profunda Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Parkinsons Dis Año: 2022 Tipo del documento: Article País de afiliación: Francia